Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant global health challenge, particularly in developing countries. This article aims to provide an updated perspective on the diagnosis and treatment of this infectious disease.
Diagnosis of enteric fever primarily relies on clinical presentation and microbiological confirmation. Blood culture is the gold standard, with sensitivity rates of 40-80%. However, it requires a sophisticated laboratory and takes time. The Widal test, though widely used due to its simplicity and cost-effectiveness, has limitations in specificity and sensitivity. Recent advances include nucleic acid amplification tests (NAATs), which offer faster results with high sensitivity and specificity, albeit at a higher cost.
Antibiotic therapy is the mainstay of enteric fever treatment. The choice of antibiotic should be guided by local susceptibility patterns. Fluoroquinolones were once the drug of choice, but increasing resistance has led to a shift towards azithromycin and third-generation cephalosporins like ceftriaxone. Resistance to multiple drugs is a growing concern, emphasizing the importance of susceptibility testing. Vaccination and improvements in sanitation and hygiene are crucial preventive measures.
The major challenges in managing enteric fever include increasing antimicrobial resistance, limited diagnostic tools in resource-poor settings, and lack of effective vaccines. Future strategies should focus on developing rapid, cost-effective diagnostic tests, new antibiotics, and more effective vaccines. Integration of genomic surveillance into public health programs can help track resistance patterns and guide treatment strategies.
In conclusion, enteric fever continues to be a significant health burden. A comprehensive approach to its diagnosis and treatment, including the development and implementation of rapid diagnostic tools, effective antibiotics, and vaccines, is essential. Continued research and surveillance are crucial to address the emerging challenges in enteric fever management.
1.
For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.
2.
FDA Advisors Recommend Galleri Multicancer Blood Test
3.
Women who miss their first mammogram face higher risk of breast cancer death, study finds
4.
Thriving while surviving: Understanding the social needs of cancer survivors
5.
Can Accelerated Salvage RT Improve Prostate Cancer Control?
1.
Fatigue and Work Participation in Blood Disease: A Comprehensive Review
2.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
3.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
4.
The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside
5.
Childhood Cancer Prevention Through Modifiable Exposure Reduction
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Hematologic Fatigue and Work Function: Clinical Implications, Pathophysiology, and Management
5.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation